Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohortsDurable responses observed at Day 85:...
-
Jersey City, New Jersey, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Branded Generics Market” By Type (Trade Named Generics, and Value-Added Branded...
-
BOSTON, Feb. 04, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced its participation in the 22nd Annual BIO CEO...